132.70 +0.38 (0.29%)
Pre-Market: 4:11AM EDT
|Bid||132.32 x 800|
|Ask||133.00 x 1300|
|Day's Range||132.30 - 133.75|
|52 Week Range||104.53 - 135.24|
|Beta (3Y Monthly)||0.54|
|PE Ratio (TTM)||14.94|
|Earnings Date||Jul 9, 2019|
|Forward Dividend & Yield||3.82 (2.85%)|
|1y Target Est||127.84|
As the sparkling water industry continues to grow, the once trending sparkling water brand La Croix is down nearly 40-percent year-to-date. Guggenheim Securities Consumer Analyst Laurent Grandet joins Yahoo Finance to discuss.
Yum Brands Inc. on Wednesday said Chris Turner, 44, will join as chief financial officer, effective Aug. 8. Turner, who previously was a senior vice president at PepsiCo Inc. , will assume global responsibility for finance, corporate strategy, supply chain, and information technology. Yum shares are flat in extended trading.
During Wednesday's edition of “Trading Nation,” Bill Baruch of Blue Line Futures said General Mills, Inc. (NYSE: GIS ) is going through some hurdles but it's not indicative of the entire sector. “You ...
Everyone knows the name Tiger Woods - golf fan or not. While the mega-star athlete has had a long and controversial career, Woods is undeniably one of the most recognizable names in sports. Woods finished the tournament tied for 6th place, but had the lead for long enough that many wondered if he could shock everyone and win.
Despite green initiatives gravitating around recycling and sustainable packaging, the Atlanta-based beverage giant is still missing the mark, according to long-time critic Greenpeace.
PepsiCo (PEP) is focusing on driving greater efficiency and effectiveness, by lowering costs and plowing back savings to develop scale and core capabilities.
Coca-Cola (KO) gains from continued innovation and investment in core categories and brands. These traits have been bolstering its quarterly performances. However, currency headwinds remain.
If there is one shipper that knows what it's like to be a motor carrier, it's Pepsico, Inc. (NYSE: PEP) chosen by FreightWaves as a "shipper of choice." The $63.5 billion beverage and snack food giant ranks first among U.S. private fleet operators with 11,100 tractors, 17,500 trailers, 3,500 straight trucks and 20,600 pick-ups and vans, according to a 2018 list compiled by Transport Topics. A recent survey by Fleet Owner places Pepsi second in private fleet size behind only telecommunications giant AT&T Corp. (NYSE: T), with 62,400 vehicles–14,300 of them trucks–and 15,000 trailers. Pepsi's Frito-Lay snack division, which accounts for nearly one quarter of all revenue and is its most profitable business, has for decades been considered one of the best private fleet operators in the world.
PepsiCo experienced strong organic revenue growth of 5.2% in the first quarter driven mainly by the performance of its Frito-Lay North America segment. However, the company doesn’t expect this impressive rate of growth to continue in the remainder of 2019.
PepsiCo (PEP) delivered higher margins in the first quarter of 2019 despite higher freight costs and commodity inflation. In the first quarter, PepsiCo’s gross margin expanded 87 basis points on a YoY (year-over-year) basis to 55.9%.
PepsiCo’s revenue rose 1.8% to $64.7 billion in 2018. Excluding the impact of structural items and currency fluctuations, the company’s revenue rose 3.7% on an organic basis in 2018. Its revenue rose 2.6% to $12.9 billion in the first quarter.
PepsiCo (PEP) stock has risen 21.4% YTD (year-to-date) as of June 20. The snack and beverage giant is ahead of its rival the Coca-Cola Company (KO) and the S&P 500 Index, which have risen 9.1% and 17.8%, respectively, since the start of this year.
With the markets near all-time highs, there has been a nice rally in cannabis stocks, but Aurora Cannabis (NYSE:ACB) seems to have missed the memo. ACB stock has been languishing.Source: Shutterstock During the past couple weeks, Tilray (NASDAQ:TLRY) has logged a return of 32% while Cronos Group (NASDAQ:CRON) is up about 17% and Canopy Growth (NYSE:CGC) has gained 11%.Unfortunately, ACB stock has been in an extended downtrend, going from $10 in March to $7.48.InvestorPlace - Stock Market News, Stock Advice & Trading TipsFor the year so far Aurora Cannabis stock is still up an impressive 43%. When it comes to cannabis stocks, there is usually quite a bit of volatility and this is not likely to change any time soon. * 6 Stocks Ready to Bounce on a Trade Deal The Pros And Cons of ACB StockThe bearishness with ACB has been the result of various factors. Although, perhaps the most important is the string of disappointing earnings reports. Note that the Canadian market has proven more difficult with the transitional to legalized marijuana. There have been challenges with the supply chain and retail expansion. What's more, black market sources have remained a persistent issue.But hey, such growing pains should be no surprise. If anything, the recent weakness does make ACB stock look relatively attractive. Consider that the consensus price target is $14.27, which implies 91% upside from current levels.So what are some of the catalysts to get ACB stock back on track? Well, first of all, the company is a top producer in the Canadian market. During the latest quarter, the production nearly doubled to 15,000 kilograms. But with the acquisition of MedReleaf and a myriad of other investments, the potential annual capacity is a hefty 570,000 kilograms.The early experience in the Canadian market is crucial. Aurora is building a solid infrastructure, which will allow for economies of scale. This make it so the company can better compete as cannabis becomes more commoditized in the Canadian market. In fact, Aurora is already becoming a streamlined low-cost provider.But another key - especially for the long haul - is the medical business. The pipeline includes 40 in-process and completed clinical trials and case studies. There has also been continued growth in the patient base, which grew by 5% in 77,136 in the latest quarter. Other Opportunities for ACB StockAnother important development is a recent partnership with the Ultimate Fighting Championship (UFC), which is the world's largest martial arts organization. The agreement calls for an exclusive multi-year focus on clinical research using Cannabidiol (CBD), which is the compound in the cannabis sativa plant that does not produce a high. In other words, there is much potential for breakthroughs with new treatments.With the passage of the Farm bill, the CBD opportunity in the US looks promising and should be a strong catalyst for growth. During the latest earnings call, Aurora chief corporate officerCam Battley had the following to say:"We are well positioned to pursue multiple angles through our deep research and product development capabilities, our regulatory expertise as well as our extensive global hemp infrastructure which we intend to expand through acquiring the shares in HempCo, not already owned by Aurora. CBD for both medical and wellness applications has incredible potential and we intend to fully leverage our capabilities, our infrastructure and our partnership potential to maximize shareholder value creation." Bottom Line on ACB StockIn mid-May, Aurora brought on board as a strategic advisor Nelson Peltz, who is the CEO of Trian Fund Management. He has decades of experience with consumer markets, with investments in companies like PepsiCo (NASDAQ:PEP), Keurig Dr Pepper (NYSE:KDP), Procter & Gamble (NYSE:PG) and Mondelez (NASDAQ:MDLZ).Peltz's involvement is a strong validator. He should also be essential in finding strategic partners.Of course, even with the advantages, ACB stock still has lots of risks. But for investors looking for an interesting cannabis play, this one definitely is worth considering.Tom Taulli is the author of the upcoming book, Artificial Intelligence Basics: A Non-Technical Introduction. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Blue-Chip Stocks to Buy for a Noisy Market * 5 Strong Buy Biotech Stocks for the Second Half * 6 Stocks Ready to Bounce on a Trade Deal Compare Brokers The post ACB Stock Is a Buy Because Aurora Cannabis Won't Get Left in the Dust appeared first on InvestorPlace.
Monster Beverage (MNST) is benefiting from brand strength, constant product launches and innovations. Further, the company is on track with growth in its international markets.
The wishlist is long, with Atlanta already securing the NCAA Final Four for 2020 and Major League Baseball’s All-Star Game in 2021. But all these events come at a cost.
Keurig Dr Pepper (KDP) gains from long-term strategies and strong market share growth across portfolio. But soft CSD category, higher input costs and currency headwinds are hurting sales.
Jeff Haag, vice president of investments at Carmel Partners, told Denver Business Journal that his firm is working on a site development plan for the lots and hopes to have something more solidified by year's end. The firm has historically focused on multifamily projects.
Quibi doesn’t launch until next year, and already Jeffrey Katzenberg’s mobile platform for “quick bites” of high-end content has sold two-thirds of its ad inventory.